Helsana HealthInvest AG

Helsana HealthInvest AG is a corporate venture capital firm established in 2020 as a subsidiary of Helsana, a leading Swiss health insurance provider. The firm focuses on investing in European digital health startups with validated and certified products ready to scale into or out of Switzerland. By providing financial support and leveraging Helsana's extensive expertise and network within the Swiss healthcare system, Helsana HealthInvest aims to improve the quality and efficiency of healthcare services.

The firm's investment strategy targets early-stage companies, particularly those in Series A and B funding rounds, with initial investments ranging from CHF 1 to 5 million. Geographically, Helsana HealthInvest concentrates on Europe, with a specific emphasis on the DACH (Germany, Austria, Switzerland), Benelux (Belgium, Netherlands, Luxembourg), and Nordic (Denmark, Finland, Norway, Sweden) regions. While the primary focus is on digital health, the firm is also open to investments in fintech, insurtech, and cybersecurity sectors, given Helsana's background as an insurer.

Helsana HealthInvest's portfolio includes companies like Humanoo, a Berlin-based B2B digital wellness solution, and Hedera Dx, a company specializing in digital health diagnostics. Through these investments, Helsana HealthInvest contributes to the advancement of healthcare innovation, aiming to enhance patient care and operational efficiency within the Swiss healthcare system.